Pradaxa is marketed to patients and physicians as a superior blood thinner and treatment for multiple conditions that increase the risk of stroke. Unfortunately, Boehringer Ingelheim, the German drug company responsible for Pradaxa, does not disclose to patients and to their doctors the true risks of the drugs, particularly for certain patients with underlying conditions. As a result, many individuals taking Pradaxa suffer severe bleeding injuries and even death.
What is Pradaxa and Who Takes It?
Atrial fibrillation (“Afib”) is the most common arrhythmia (or irregular heartbeat) diagnosed in clinical practice and the U.S. Center for Disease Control estimates that nearly 10% of seniors suffer from AFib. This irregular heartbeat condition can cause blood to pool in the heart, increasing the risk of developing a blood clot or stroke—a blood clot that travels to the brain or brain stem. Blood thinners, like Pradaxa, are prescribed to help reduce the risk of stroke.
While all blood thinners, like Coumadin (or Warfarin), Xarelto, and Eliquis, increase the risk of suffering a bleeding injury, Pradaxa carries special, increased risks for certain patients, like women, the elderly, and those patients, who are also taking certain medications. For certain patients, Pradaxa may not be the safest option. Unfortunately, these risks are not spelled out for patients and for physicians. And the drug company, despite understanding how to identify at-risk patients, does not tell physicians how to do so. As a result, those at risk of having a serious bleeding injury aren’t identified early and instead many suffer serious (even fatal) bleeding injuries.
History of Pradaxa Lawsuits
Shortly after Pradaxa was initially approved by the FDA in 2010, Pradaxa patients were already starting to file wrongful death and personal injury lawsuits against the manufacturer after suffering serious bleeding injuries. By August 2012, approximately 4,000 claims had been filed in federal court. In 2014, Boehringer Ingelheim agreed to pay $650 million to settle all of its 4,000 lawsuits, but the Company did not change its label to address the underlying problems.
As a result, to this day, patients and their families continue to file lawsuits related to severe bleeding injuries suffered while on Pradaxa. Several Pradaxa trials have been conducted across the country, including two verdicts for the Plaintiff. Notably, both juries indicated that Boehringer Ingelheim had shown a conscious disregard for the safety of patients and awarded punitive damages.
How Do I Know if I Have a Pradaxa Lawsuit?
If you or a loved one have suffered a bleeding injury while on Pradaxa, you could be entitled to compensation including for pain and suffering, medical bills, lost wages and other financial losses. It is important that you have your Pradaxa case evaluated by a law firm with decades of experience in litigating lawsuits involving defective products. Levy Konigsberg has a proven track record spanning over thirty years. Our firm has obtained landmark jury verdicts and settlements against large corporations who have put profit over public safety. Contact our experienced and compassionate lawyers today for a free evaluation of your potential Pradaxa lawsuit. We will not recovery any attorney’s fees unless we recover money for you. To contact us now, call the number on the screen, fill out our short website form or have a live chat with us now.